Latest Research About Neurostimulation

Latest Research About Neurostimulation

MagnoVision™ MG10 Batıgöz

Magnovision Treatment:

A Supportive Approach in

Retinal Diseases

25.12.2025

Üsküdar, İstanbul, Türkiye

Magnovision has been featured by Batıgöz

Health Group as an innovative

electromagnetic stimulation–based

supportive therapy targeting retinal and

optic nerve cells in patients with visual

impairment.

> Learn More

MagnoVision™ MG10 Optik Gazete

Next-Generation Technology

Against Vision Loss:

MagnoVision

12.01.2026

Magnovision continues to be discussed

across clinical platforms and medical

publications as a promising supportive

technology in the field of retinal and

optic nerve health.

> Learn More

MagnoVision™ MG10 OTC PLUS




Next-Generation Technology

Against Vision Loss:

MagnoVision


20.12.2025

OTC Plus Magazine highlights Magnovision

as a new-generation medical technology

developed to support patients with retinal

diseases, emphasizing its non-invasive

and complementary therapeutic approach.

> Learn More

MagnoVision™ MG10 ERAGÖZ

Magnovision in Scientific and

Clinical Discussions

25.12.2025

Muratpaşa, Antalya, Türkiye

Özel Era Eye Diseases Center presents

MagnoViison™ as a supportive medical

device used alongside existing treatment

methods in selected retinal and optic nerve

conditions.

> Learn More

Press Releases

MagnoVision™ MG10 Batıgöz

Magnovision Treatment:

A Supportive Approach in

Retinal Diseases

25.12.2025

Üsküdar, İstanbul, Türkiye

Magnovision has been featured by Batıgöz

Health Group as an innovative

electromagnetic stimulation–based

supportive therapy targeting retinal and

optic nerve cells in patients with visual

impairment.

> Learn More

MagnoVision™ MG10 Optik Gazete

Next-Generation Technology

Against Vision Loss:

MagnoVision

12.01.2026

Magnovision continues to be discussed

across clinical platforms and medical

publications as a promising supportive

technology in the field of retinal and

optic nerve health.

> Learn More

MagnoVision™ MG10 OTC PLUS




Next-Generation Technology

Against Vision Loss:

MagnoVision


20.12.2025

OTC Plus Magazine highlights Magnovision

as a new-generation medical technology

developed to support patients with retinal

diseases, emphasizing its non-invasive

and complementary therapeutic approach.

> Learn More

MagnoVision™ MG10 ERAGÖZ

Magnovision in Scientific and

Clinical Discussions

25.12.2025

Muratpaşa, Antalya, Türkiye

Özel Era Eye Diseases Center presents

MagnoViison™ as a supportive medical

device used alongside existing treatment

methods in selected retinal and optic nerve

conditions.

> Learn More

Press Releases

Innovative solutions for ophthalmology.

Committed to improving vision and

empowering eye care professionals.

Contact


info@bioretina.com.tr

+90 (312) 235 85 10

+90 (530) 321 75 90

Erler Mah. Dumlupınar Bulvarı Üstün
Dekocity İş Merkezi No:348/68
Etimesgut/ANKARA/TÜRKİYE

Innovative solutions for ophthalmology.

Committed to improving vision and

empowering eye care professionals.

Contact


info@bioretina.com.tr

+90 (312) 235 85 10

+90 (530) 321 75 90

Erler Mah. Dumlupınar Bulvarı Üstün
Dekocity İş Merkezi No:348/68
Etimesgut/ANKARA/TÜRKİYE